Trials / Completed
CompletedNCT01913964
Acetyl-L-Carnitine Supplementation During HCV Therapy With Pegylated Interferon-α2b Plus Ribavirin
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- —
- Sponsor
- University of Catania · Academic / Other
- Sex
- All
- Age
- 45 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
To assess the effects of Acetyl-L-Carnitine administration on work productivity, daily activity, and fatigue in subjects with chronic hepatitis C treated with Pegylated-Interferon-α2b and Ribavirin.
Conditions
- Work Productivity and Activity Impairment in Workers With Chronic C Hepatitis
- Fatigue in Workers With Chronic C Hepatitis
- Fatigue
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Acetylcarnitine | |
| DRUG | Placebo | (sugar pill) |
Timeline
- Start date
- 1997-10-01
- Primary completion
- 1997-10-01
- Completion
- 1997-10-01
- First posted
- 2013-08-01
- Last updated
- 2013-08-01
Source: ClinicalTrials.gov record NCT01913964. Inclusion in this directory is not an endorsement.